urea has been researched along with AIDS Seroconversion in 4 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Drug-related adverse effects were flulike symptoms, gingivitis, fever, local erythema, and eosinophilia." | 2.69 | Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals. ( Gorter, RW; Stoss, M; van Wely, M, 1999) |
| "Urea treatment preferentially eluted MAbs to discontinuous rather than continuous epitopes, independent of their affinities." | 1.30 | An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1. ( Arshad, H; Binley, JM; Fouts, TR; Moore, JP, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stuart-Clark, H | 1 |
| Vorajee, N | 1 |
| Zuma, S | 1 |
| Van Niekerk, L | 1 |
| Burch, V | 1 |
| Raubenheimer, P | 1 |
| Peter, JG | 1 |
| Kostiushov, VV | 1 |
| Binley, JM | 1 |
| Arshad, H | 1 |
| Fouts, TR | 1 |
| Moore, JP | 1 |
| van Wely, M | 1 |
| Stoss, M | 1 |
| Gorter, RW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Controlled Trial of an Integrated Post-discharge Transitional Care Package for General Medical In-patients in Cape Town, South Africa[NCT01916876] | 0 participants (Actual) | Interventional | 2015-03-31 | Withdrawn (stopped due to Funding shortage) | |||
| "Validation Study of the 4-question RACYDelirium Screening Tool in General Medical In-patients From a Developing Country Setting"[NCT01916889] | 1,093 participants (Actual) | Interventional | 2013-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for urea and AIDS Seroconversion
| Article | Year |
|---|---|
Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals.
Topics: Adjuvants, Immunologic; Adult; Antibodies; Blood Proteins; Dose-Response Relationship, Drug; Female; | 1999 |
3 other studies available for urea and AIDS Seroconversion
| Article | Year |
|---|---|
Twelve-month outcomes of patients admitted to the acute general medical service at Groote Schuur Hospital.
Topics: Activities of Daily Living; Adult; Age Factors; Aged; Confidence Intervals; Employment; Female; Foll | 2012 |
Twelve-month outcomes of patients admitted to the acute general medical service at Groote Schuur Hospital.
Topics: Activities of Daily Living; Adult; Age Factors; Aged; Confidence Intervals; Employment; Female; Foll | 2012 |
Twelve-month outcomes of patients admitted to the acute general medical service at Groote Schuur Hospital.
Topics: Activities of Daily Living; Adult; Age Factors; Aged; Confidence Intervals; Employment; Female; Foll | 2012 |
Twelve-month outcomes of patients admitted to the acute general medical service at Groote Schuur Hospital.
Topics: Activities of Daily Living; Adult; Age Factors; Aged; Confidence Intervals; Employment; Female; Foll | 2012 |
[Clinical significance of parameters of the thiol-dependent mechanism of the biochemical phase of interaction between serum proteins and urea in HIV-infection].
Topics: Acquired Immunodeficiency Syndrome; Blood Proteins; Disulfides; HIV Infections; HIV Seropositivity; | 2003 |
An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Antibody Affinity; Antigen-Antibody Complex; HIV Antibo | 1997 |